A pharmaceutical composition incorporating an angiotensin II receptor AT1 antagonist and an immunosuppressant for the prevention or treatment of vascular complications of graft rejection

摘要

The present invention relates to pharmaceutical compositions and immunosuppressants containing angiotensin II receptor AT1 antagonists, in particular irbesartan, especially the use of cyclosporin A in preventing or treating vascular complications after transplantation rejection.